文献速递复苏、休克与脓毒症消化、代谢与肾脏急症

白蛋白、乳酸/白蛋白比值和C反应蛋白/白蛋白比值在感染患者中的预后作用

Prognostic role of albumin, lactate-to-albumin ratio and C-reactive protein-to-albumin ratio in infected patients.
PubMed 文献 · Am J Emerg Med · 2024-01-05
一句话结论在急诊感染患者中,白蛋白、乳酸/白蛋白比值(LAR)和C反应蛋白/白蛋白比值(CAR)对30天死亡均有良好区分能力,白蛋白AUROC最高(0.831)。

该单中心前瞻性研究于2021年1月1日至2021年12月31日在意大利Merano医院急诊科纳入962例感染患者,主要终点为30天内死亡。30天总死亡率为8.9%(86/962)。白蛋白AUROC为0.831(95%CI 0.795-0.868),LAR为0.773(95%CI 0.719-0.827),CAR为0.718(95%CI 0.664-0.771)。多因素logistic回归显示白蛋白OR 3.362(95%CI 1.904-5.936)、ln(LAR) OR 2.651(95%CI 1.646-4.270)、ln(CAR) OR 1.739(95%CI 1.326-2.281)与30天死亡相关。作者认为三个指标在急诊和ICU均有应用前景,但需进一步研究确认白蛋白优于LAR和CAR。

要点

  • 急诊感染患者30天死亡率为8.9%(86/962),白蛋白对30天死亡的AUROC为0.831(95%CI 0.795-0.868),高于LAR的0.773(95%CI 0.719-0.827)和CAR的0.718(95%CI 0.664-0.771)。
  • 多因素logistic回归中,白蛋白与30天死亡的OR为3.362(95%CI 1.904-5.936),ln(LAR) OR为2.651(95%CI 1.646-4.270),ln(CAR) OR为1.739(95%CI 1.326-2.281),协变量包括合并症、急性紧急程度和感染严重程度。
  • 作者认为三个指标在急诊和ICU均有应用前景,但需进一步研究确认白蛋白是否优于LAR和CAR。
  • 研究为意大利Merano医院急诊科单中心前瞻性研究,纳入2021年1月1日至2021年12月31日所有感染患者。

适用人群与场景

  • 2021年1月1日至2021年12月31日在意大利Merano医院急诊科就诊的所有感染患者,共962例。

研究设计与关键结果

  • 单中心前瞻性研究,纳入962例急诊感染患者,主要终点为30天内死亡,30天总死亡率为8.9%(86/962)。
  • 白蛋白预测30天死亡的AUROC为0.831(95%CI 0.795-0.868),LAR为0.773(95%CI 0.719-0.827),CAR为0.718(95%CI 0.664-0.771)。
  • 多因素logistic回归(协变量为合并症、急性紧急程度和感染严重程度)中,白蛋白与30天死亡的OR为3.362(95%CI 1.904-5.936),ln(LAR) OR为2.651(95%CI 1.646-4.270),ln(CAR) OR为1.739(95%CI 1.326-2.281)。

证据类型、等级与局限

  • 证据类型:单中心前瞻性研究。
  • 局限:原文未报告局限性;作者在结论中提出需进一步研究确认白蛋白相比LAR和CAR的更好性能。

对床旁实践的改变

  • 作者认为白蛋白、LAR和CAR三个指标对急诊感染患者短期死亡风险有良好区分能力,在急诊和ICU均有应用前景。
  • 作者认为需进一步研究确认白蛋白相比LAR和CAR的更好性能。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The prognostic evaluation of the septic patient has recently been enriched by some predictive indices such as albumin concentration, lactate/albumin ratio (LAR) and C-reactive protein/albumin ratio (CAR). The performance of these indices has been evaluated in septic patients in intensive care, but until now their performance in infected patients in the Emergency Department (ED) has not been evaluated.

AIM: To investigate the potential prognostic role of albumin, LAR and CAR in patients with infection in the ED.

METHODS: Single-centre prospective study performed between 1 January 2021 and 31 December 2021 at the ED of the Merano Hospital (Italy). All patients with infection were enrolled. The study outcome was death within 30 days. The predictive ability of albumin, LAR and CAR was assessed by area under the receiver operating characteristic curves (AUROCs). A multivariate logistic regression model was used to examine the association of the indices with 30-day mortality, with comorbidity, acute urgency and severity of infection as covariates.

RESULTS: The study enrolled 962 patients with an infectious status. The overall 30-day mortality rate was 8.9% (86/962). The AUROC of albumin was 0.831 (95% CI 0.795-868), while for LAR this was 0.773 (CI95% 0.719-0.827) and for CAR 0.718 (CI95% 0.664-0.771). The odds ratio for 30-day mortality for albumin was 3.362 (95% CI 1.904-5.936), for ln(LAR) 2.651 (95% CI 1.646-4.270) and for ln(CAR) 1.739 (95% CI 1.326-2.281).

CONCLUSIONS: All three indices had a good discriminatory ability for the risk of short-term death in patients with infection, indicating their promising use in the ED as well as in the ICU. Further studies are needed to confirm the better performance of albumin compared to LAR and CAR.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Turcato G, Zaboli A, Sibilio S, et al. Prognostic role of albumin, lactate-to-albumin ratio and C-reactive protein-to-albumin ratio in infected patients. Am J Emerg Med. 2024. PMID: 38199095. doi:10.1016/j.ajem.2023.12.042

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。